| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385500A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 02/04/2004 | EP1385495A2 Sulfonamides |
| 02/04/2004 | EP1385494A2 Aerosol compositions containing formoterol and a steroid such as e.g. budesonide or fluticasone for delivery into the lungs |
| 02/04/2004 | EP1196409B1 Respiratory syncytial virus replication inhibitors |
| 02/04/2004 | EP1042319B1 Dihydrobenzofurans |
| 02/04/2004 | EP1021196B1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 02/04/2004 | EP0820414B1 Metered dose inhaler for beclomethasone dipropionate |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473148A Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy-4(S)-[N-(4- phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing crystals as active ingredient |
| 02/04/2004 | CN1473055A Methods for enhancing efficacy of cytotoxic agents through use of HSP90 inhibitors |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1473044A Inhalative solution formulation containing tiotropium salt |
| 02/04/2004 | CN1473038A Inhalative solution formulation containing tiotropium salt |
| 02/04/2004 | CN1472332A Target for medicine against Sars-Cov and medicine screening method and medicine against Sars |
| 02/04/2004 | CN1471981A Surface treatment for SARS lungs bacteria infection |
| 02/04/2004 | CN1471968A Medicinal use of recombined human interleukin-1 receptor antagonist |
| 02/04/2004 | CN1471929A Chinese patent drug for treating nasosinusitis |
| 02/04/2004 | CN1471923A Spray for treating asthma and its preparing method |
| 02/04/2004 | CN1471922A Spray contaniing heparin and lipoid, preparing method thereof |
| 02/04/2004 | CN1471918A Oral liquid medicine for benzopirnie phosphate and its preparing method |
| 02/04/2004 | CN1471914A Medicine, application and preparing method for preventnig SARS pneumonia by SARS virus |
| 02/04/2004 | CN1137125C Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 02/04/2004 | CN1136903C Shaddock-lozenge tablet and its producing method |
| 02/04/2004 | CN1136901C Medicine for treating chronic pharyngitis and its prepn |
| 02/04/2004 | CN1136885C Chinese medicine for treating dyspneic cough effectively |
| 02/04/2004 | CN1136881C Combined Chinese and Western medicine for treating pulmonary emphysema |
| 02/04/2004 | CN1136880C Combined Chinese Western medicine for treating bronchial asthma |
| 02/04/2004 | CN1136879C Combined Chinese and Western medicine for treating chronic bronchitis in catabasis |
| 02/04/2004 | CN1136875C Chuqin Zihou San and its preparing process |
| 02/04/2004 | CN1136867C Antivirus compound medicine |
| 02/04/2004 | CN1136861C 'Lifeiqing' capsule for treating pulmonary tuberculosis |
| 02/04/2004 | CN1136860C External medicine for curing respiratory tract disease |
| 02/04/2004 | CN1136851C Medicine for curing bronchial asthma and asthmatic chronic bronchitis and its preparing process |
| 02/03/2004 | US6686484 Anticoagulants; serine protease inhibitor |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |
| 02/03/2004 | US6686366 Compounds specific to adenosine A3 receptor and uses thereof |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686349 Administering to a patient for the treatment of sexual dysfunction an effective amount of substituted tetracyclic pyrroloquinolone derivatives |
| 02/03/2004 | US6686343 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents |
| 02/03/2004 | US6686155 Treatment of tumor; obtain tissue sample, extract nucleotide sequences, amplify, detect preferential nucleotide sequences, incbate with antitumor agent, monitor sequence expression, adjustment in expression indicates effective antitumor agent |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685917 Treatment of mucositis |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009592A1 Bicyclic unsaturated tertiary amine compound |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009583A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009555A1 5-substituted isoquinoline derivative |
| 01/29/2004 | WO2004009550A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | WO2004009528A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | WO2004009099A1 Phosphorylated dextran |
| 01/29/2004 | WO2004009098A1 Antisense compounds, methods and compositions for treating mmp-12 related inflammatory disorders |
| 01/29/2004 | WO2004009061A2 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 01/29/2004 | WO2004009058A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 01/29/2004 | WO2004009030A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/29/2004 | WO2003088748A8 Use of heme oxygenase-1 and products of heme degradation |
| 01/29/2004 | WO2003072572A8 Beta3-adrenergic receptor agonists |
| 01/29/2004 | WO2003053923A3 Pyrrolidine derivatives as prostaglandin modulators |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | US20040019210 Kinase inhibitors |
| 01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
| 01/29/2004 | US20040019207 Amines such as 8-Benzyl-3-(3-pyridyl)-8-azabicyclo(3.2.1) oct-2-ene, that bind to nicotinic acetocholine receptors, used for prophylaxis of nervous system disorders, as analgesis, antiinflammatory agents and drug abuse |
| 01/29/2004 | US20040019191 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 01/29/2004 | US20040019184 Remedies for ischemic disease |
| 01/29/2004 | US20040019114 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019099 Treating inflammatory diseases, allergic conditions and central nervous system disorders |
| 01/29/2004 | US20040019071 Preferential opiate receptors, used as analgesics, antitussive agents, immunosuppressants or neuroprotectants; side effect reduction |
| 01/29/2004 | US20040019070 Nitrogen compounds used as opiate receptor agonists or antagonists, for prophylaxis of drug abuse, cardiovascular, respiratory system, gastrointestinal disorders, as analgesics, antitussives or immunosuppressants |
| 01/29/2004 | US20040019048 Imidazo(4,5-c)quinoline and the 6,7,8,9-tetrahydro derivative having urea, thiourea, acylurea or sulfonylurea at the 1-position as immune response modifiers; biosynthesis of cytokines; viricides; antitumor, -carcinogenic agents |
| 01/29/2004 | US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/29/2004 | US20040019040 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040019034 Pyrrolotriazolopyrimidinone derivatives |
| 01/29/2004 | US20040019011 Treatment of conitions and disease |
| 01/29/2004 | US20040018995 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; antidiabetic agents |
| 01/29/2004 | US20040018981 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018327 Delayed release dosage forms |
| 01/29/2004 | US20040018251 Petasite extract is recovered from plant of the genus Petasites; effective in treating gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure |
| 01/29/2004 | US20040018243 Modulation of release from dry powder formulations |
| 01/29/2004 | US20040018233 An expectorant drug delivery dosage forms comprises a sustained release portion and an immediate release portion; relieving from bronchial mucus accumulation |
| 01/29/2004 | US20040016435 Methods and devices for use in performing pulmonary procedures |